Dr. Schade is a UW assistant professor in urology and adjunct assistant professor in the UW center for industrial and medical ultrasound and applied physics lab.
Dr. Schade specializes in urologic oncology, with a specific focus on bladder, prostate, kidney and testicular cancers. He performs open, laparoscopic and robotic surgery.
Dr. Schade earned his B.A in biology and M.D. from the The University of Chicago. He then completed his urology residency at the University of Michigan. After residency, he headed west where he completed a Society of Urologic Oncology Accredited Fellowship in urologic oncology at the University of Washington where he then joined the Department of Urology as faculty.
Dr. Schade is a Urology Care Foundation Research Scholar.
Dr. Schade is a member of the American Urologic Association, Western Section of the American Urologic Association, Society of Urologic Oncology, International Society for Therapeutic Ultrasound, and Alpha Omega Alpha.
Patient Care Philosophy
I strive to provide high-quality compassionate care tailored to each patient’s individual circumstances, while including each patient as an active member of the team.
Minimally invasive and robotic surgery for urologic cancers.
Dr Schade’s primary research interest is in technology development aimed at improving urologic cancer diagnosis and treatment. In particular, he is developing a non-invasive ultrasound based treatment for kidney cancer. He also studies the impact of urologic cancers on patients’ quality of life and how other medical problems can impact cancer treatment outcomes.
|Univ. of Michigan - Dept. of Surgery||Internship||2008|
|University of Michigan||Residency||2013|
|UW - Dept. of Urology||Fellowship||2015|
|Univ. of Chicago Pritzker Sch of Med||Medical education||2007|